nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.126	0.17	CbGbCtD
Dihydrocodeine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.126	0.17	CbGbCtD
Dihydrocodeine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.113	0.152	CbGbCtD
Dihydrocodeine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.106	0.143	CbGbCtD
Dihydrocodeine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0716	0.0966	CbGbCtD
Dihydrocodeine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0683	0.0921	CbGbCtD
Dihydrocodeine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0609	0.0821	CbGbCtD
Dihydrocodeine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0357	0.0482	CbGbCtD
Dihydrocodeine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0337	0.0455	CbGbCtD
Dihydrocodeine—Ileus paralytic—Tiotropium—chronic obstructive pulmonary disease	0.00813	0.0353	CcSEcCtD
Dihydrocodeine—Galantamine—CHRNA5—chronic obstructive pulmonary disease	0.00557	0.519	CrCbGaD
Dihydrocodeine—Pulmonary function test decreased—Aminophylline—chronic obstructive pulmonary disease	0.00495	0.0215	CcSEcCtD
Dihydrocodeine—Respiratory depression—Aminophylline—chronic obstructive pulmonary disease	0.00495	0.0215	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00296	0.0129	CcSEcCtD
Dihydrocodeine—Withdrawal syndrome—Prednisone—chronic obstructive pulmonary disease	0.00267	0.0116	CcSEcCtD
Dihydrocodeine—Galantamine—CHRNA3—chronic obstructive pulmonary disease	0.00261	0.243	CrCbGaD
Dihydrocodeine—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.00257	0.0112	CcSEcCtD
Dihydrocodeine—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00254	0.011	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00253	0.011	CcSEcCtD
Dihydrocodeine—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.00246	0.0107	CcSEcCtD
Dihydrocodeine—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.00243	0.0105	CcSEcCtD
Dihydrocodeine—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00223	0.00971	CcSEcCtD
Dihydrocodeine—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.0022	0.00954	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00207	0.00898	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00196	0.0085	CcSEcCtD
Dihydrocodeine—Dextromethorphan—CHRNA3—chronic obstructive pulmonary disease	0.00195	0.182	CrCbGaD
Dihydrocodeine—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00194	0.00842	CcSEcCtD
Dihydrocodeine—Affect lability—Salbutamol—chronic obstructive pulmonary disease	0.00191	0.00832	CcSEcCtD
Dihydrocodeine—Mood swings—Salbutamol—chronic obstructive pulmonary disease	0.00184	0.00801	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.00174	0.00758	CcSEcCtD
Dihydrocodeine—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.00173	0.00752	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00172	0.00748	CcSEcCtD
Dihydrocodeine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00171	0.00741	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00164	0.00714	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00163	0.00709	CcSEcCtD
Dihydrocodeine—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.0016	0.00696	CcSEcCtD
Dihydrocodeine—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00159	0.00693	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00159	0.00692	CcSEcCtD
Dihydrocodeine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00158	0.00689	CcSEcCtD
Dihydrocodeine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00158	0.00685	CcSEcCtD
Dihydrocodeine—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.00155	0.00672	CcSEcCtD
Dihydrocodeine—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00151	0.0863	CbGpPWpGaD
Dihydrocodeine—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.00147	0.00639	CcSEcCtD
Dihydrocodeine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00141	0.00614	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.00141	0.00612	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.00141	0.00612	CcSEcCtD
Dihydrocodeine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.0014	0.0061	CcSEcCtD
Dihydrocodeine—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.0014	0.00607	CcSEcCtD
Dihydrocodeine—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.00607	CcSEcCtD
Dihydrocodeine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00139	0.00604	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.00138	0.00599	CcSEcCtD
Dihydrocodeine—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.00137	0.00595	CcSEcCtD
Dihydrocodeine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00136	0.00593	CcSEcCtD
Dihydrocodeine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00134	0.0763	CbGpPWpGaD
Dihydrocodeine—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00578	CcSEcCtD
Dihydrocodeine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00132	0.00573	CcSEcCtD
Dihydrocodeine—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00573	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.0013	0.00567	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.0013	0.00565	CcSEcCtD
Dihydrocodeine—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00129	0.00559	CcSEcCtD
Dihydrocodeine—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00129	0.00559	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00128	0.00558	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.00558	CcSEcCtD
Dihydrocodeine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00128	0.00556	CcSEcCtD
Dihydrocodeine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00127	0.00551	CcSEcCtD
Dihydrocodeine—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00126	0.00548	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00126	0.00547	CcSEcCtD
Dihydrocodeine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00126	0.00547	CcSEcCtD
Dihydrocodeine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00126	0.00546	CcSEcCtD
Dihydrocodeine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00125	0.00543	CcSEcCtD
Dihydrocodeine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00543	CcSEcCtD
Dihydrocodeine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00543	CcSEcCtD
Dihydrocodeine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00124	0.0054	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.00535	CcSEcCtD
Dihydrocodeine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00531	CcSEcCtD
Dihydrocodeine—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00531	CcSEcCtD
Dihydrocodeine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00122	0.0053	CcSEcCtD
Dihydrocodeine—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00528	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00527	CcSEcCtD
Dihydrocodeine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.00515	CcSEcCtD
Dihydrocodeine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00512	CcSEcCtD
Dihydrocodeine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00493	CcSEcCtD
Dihydrocodeine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00493	CcSEcCtD
Dihydrocodeine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.0049	CcSEcCtD
Dihydrocodeine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00483	CcSEcCtD
Dihydrocodeine—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.0011	0.00477	CcSEcCtD
Dihydrocodeine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00109	0.0624	CbGpPWpGaD
Dihydrocodeine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00109	0.00473	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00108	0.00471	CcSEcCtD
Dihydrocodeine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00107	0.00466	CcSEcCtD
Dihydrocodeine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00465	CcSEcCtD
Dihydrocodeine—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.00106	0.00459	CcSEcCtD
Dihydrocodeine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00106	0.00459	CcSEcCtD
Dihydrocodeine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00458	CcSEcCtD
Dihydrocodeine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00457	CcSEcCtD
Dihydrocodeine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.00457	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00456	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00456	CcSEcCtD
Dihydrocodeine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00449	CcSEcCtD
Dihydrocodeine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00449	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00446	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00446	CcSEcCtD
Dihydrocodeine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000996	0.00433	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000993	0.00432	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000993	0.00432	CcSEcCtD
Dihydrocodeine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000991	0.00431	CcSEcCtD
Dihydrocodeine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000983	0.00427	CcSEcCtD
Dihydrocodeine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000983	0.00427	CcSEcCtD
Dihydrocodeine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000975	0.00424	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000972	0.00423	CcSEcCtD
Dihydrocodeine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000963	0.00419	CcSEcCtD
Dihydrocodeine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000946	0.00411	CcSEcCtD
Dihydrocodeine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000946	0.00411	CcSEcCtD
Dihydrocodeine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000941	0.00409	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000937	0.00407	CcSEcCtD
Dihydrocodeine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000928	0.00404	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000924	0.00402	CcSEcCtD
Dihydrocodeine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00091	0.00396	CcSEcCtD
Dihydrocodeine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000902	0.00392	CcSEcCtD
Dihydrocodeine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000902	0.00392	CcSEcCtD
Dihydrocodeine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.0009	0.00391	CcSEcCtD
Dihydrocodeine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.0009	0.00391	CcSEcCtD
Dihydrocodeine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000893	0.00388	CcSEcCtD
Dihydrocodeine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00089	0.00387	CcSEcCtD
Dihydrocodeine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000887	0.00386	CcSEcCtD
Dihydrocodeine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000881	0.00383	CcSEcCtD
Dihydrocodeine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000879	0.00382	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000874	0.0038	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000874	0.0038	CcSEcCtD
Dihydrocodeine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000866	0.00376	CcSEcCtD
Dihydrocodeine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000866	0.00376	CcSEcCtD
Dihydrocodeine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000858	0.00373	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000856	0.00372	CcSEcCtD
Dihydrocodeine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000852	0.0037	CcSEcCtD
Dihydrocodeine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00085	0.00369	CcSEcCtD
Dihydrocodeine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000846	0.00368	CcSEcCtD
Dihydrocodeine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000839	0.00365	CcSEcCtD
Dihydrocodeine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000838	0.00364	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000834	0.00363	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000834	0.00363	CcSEcCtD
Dihydrocodeine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000833	0.00362	CcSEcCtD
Dihydrocodeine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000829	0.00361	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000828	0.0036	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000828	0.0036	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000825	0.00359	CcSEcCtD
Dihydrocodeine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000817	0.00355	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000811	0.00352	CcSEcCtD
Dihydrocodeine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000804	0.0035	CcSEcCtD
Dihydrocodeine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000804	0.0035	CcSEcCtD
Dihydrocodeine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.0008	0.00348	CcSEcCtD
Dihydrocodeine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.0008	0.00348	CcSEcCtD
Dihydrocodeine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000798	0.00347	CcSEcCtD
Dihydrocodeine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000797	0.00347	CcSEcCtD
Dihydrocodeine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000791	0.00344	CcSEcCtD
Dihydrocodeine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00079	0.00343	CcSEcCtD
Dihydrocodeine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00079	0.00343	CcSEcCtD
Dihydrocodeine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000788	0.00342	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000788	0.00342	CcSEcCtD
Dihydrocodeine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000786	0.00342	CcSEcCtD
Dihydrocodeine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000784	0.00341	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000781	0.0034	CcSEcCtD
Dihydrocodeine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000768	0.00334	CcSEcCtD
Dihydrocodeine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000759	0.0033	CcSEcCtD
Dihydrocodeine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000755	0.00328	CcSEcCtD
Dihydrocodeine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000745	0.00324	CcSEcCtD
Dihydrocodeine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000716	0.00311	CcSEcCtD
Dihydrocodeine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000716	0.00311	CcSEcCtD
Dihydrocodeine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000701	0.00305	CcSEcCtD
Dihydrocodeine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000693	0.00301	CcSEcCtD
Dihydrocodeine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000693	0.00301	CcSEcCtD
Dihydrocodeine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000678	0.00295	CcSEcCtD
Dihydrocodeine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000676	0.00294	CcSEcCtD
Dihydrocodeine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000669	0.00291	CcSEcCtD
Dihydrocodeine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000669	0.00291	CcSEcCtD
Dihydrocodeine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000656	0.00285	CcSEcCtD
Dihydrocodeine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000654	0.00284	CcSEcCtD
Dihydrocodeine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000644	0.0028	CcSEcCtD
Dihydrocodeine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000644	0.0028	CcSEcCtD
Dihydrocodeine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000638	0.00277	CcSEcCtD
Dihydrocodeine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000638	0.00277	CcSEcCtD
Dihydrocodeine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000638	0.00277	CcSEcCtD
Dihydrocodeine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000638	0.00277	CcSEcCtD
Dihydrocodeine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000634	0.00276	CcSEcCtD
Dihydrocodeine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000634	0.00276	CcSEcCtD
Dihydrocodeine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000632	0.00275	CcSEcCtD
Dihydrocodeine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00063	0.00274	CcSEcCtD
Dihydrocodeine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000625	0.00272	CcSEcCtD
Dihydrocodeine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000624	0.00271	CcSEcCtD
Dihydrocodeine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000621	0.0027	CcSEcCtD
Dihydrocodeine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000614	0.00267	CcSEcCtD
Dihydrocodeine—Dextromethorphan—SLC6A4—chronic obstructive pulmonary disease	0.000612	0.0569	CrCbGaD
Dihydrocodeine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000608	0.00264	CcSEcCtD
Dihydrocodeine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000603	0.00262	CcSEcCtD
Dihydrocodeine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000603	0.00262	CcSEcCtD
Dihydrocodeine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000602	0.00262	CcSEcCtD
Dihydrocodeine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000601	0.00261	CcSEcCtD
Dihydrocodeine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000601	0.00261	CcSEcCtD
Dihydrocodeine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000599	0.0026	CcSEcCtD
Dihydrocodeine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000589	0.00256	CcSEcCtD
Dihydrocodeine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000582	0.00253	CcSEcCtD
Dihydrocodeine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000568	0.00247	CcSEcCtD
Dihydrocodeine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000558	0.00243	CcSEcCtD
Dihydrocodeine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000555	0.0317	CbGpPWpGaD
Dihydrocodeine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00053	0.0023	CcSEcCtD
Dihydrocodeine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000509	0.00221	CcSEcCtD
Dihydrocodeine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000506	0.0022	CcSEcCtD
Dihydrocodeine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000492	0.00214	CcSEcCtD
Dihydrocodeine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000491	0.00214	CcSEcCtD
Dihydrocodeine—OPRM1—Opioid Signalling—PDE4A—chronic obstructive pulmonary disease	0.000464	0.0265	CbGpPWpGaD
Dihydrocodeine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000452	0.00196	CcSEcCtD
Dihydrocodeine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000446	0.00194	CcSEcCtD
Dihydrocodeine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000438	0.00191	CcSEcCtD
Dihydrocodeine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000438	0.025	CbGpPWpGaD
Dihydrocodeine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000435	0.00189	CcSEcCtD
Dihydrocodeine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000425	0.0243	CbGpPWpGaD
Dihydrocodeine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000423	0.00184	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000413	0.00179	CcSEcCtD
Dihydrocodeine—OPRM1—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.000402	0.023	CbGpPWpGaD
Dihydrocodeine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000391	0.0017	CcSEcCtD
Dihydrocodeine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000387	0.00168	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000385	0.00167	CcSEcCtD
Dihydrocodeine—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000366	0.0209	CbGpPWpGaD
Dihydrocodeine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000362	0.00158	CcSEcCtD
Dihydrocodeine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000358	0.00155	CcSEcCtD
Dihydrocodeine—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000352	0.0201	CbGpPWpGaD
Dihydrocodeine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000346	0.0015	CcSEcCtD
Dihydrocodeine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000345	0.0015	CcSEcCtD
Dihydrocodeine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000343	0.00149	CcSEcCtD
Dihydrocodeine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000341	0.00148	CcSEcCtD
Dihydrocodeine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00033	0.0188	CbGpPWpGaD
Dihydrocodeine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000328	0.00143	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000326	0.00142	CcSEcCtD
Dihydrocodeine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000326	0.00142	CcSEcCtD
Dihydrocodeine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000318	0.0182	CbGpPWpGaD
Dihydrocodeine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000316	0.00138	CcSEcCtD
Dihydrocodeine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000315	0.00137	CcSEcCtD
Dihydrocodeine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000286	0.0164	CbGpPWpGaD
Dihydrocodeine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000282	0.00123	CcSEcCtD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—IL17A—chronic obstructive pulmonary disease	0.00028	0.016	CbGpPWpGaD
Dihydrocodeine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000273	0.00118	CcSEcCtD
Dihydrocodeine—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000272	0.0155	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000266	0.0152	CbGpPWpGaD
Dihydrocodeine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000263	0.00115	CcSEcCtD
Dihydrocodeine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00026	0.0149	CbGpPWpGaD
Dihydrocodeine—OPRM1—IL4-mediated signaling events—IL10—chronic obstructive pulmonary disease	0.000257	0.0147	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000256	0.0146	CbGpPWpGaD
Dihydrocodeine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000253	0.0011	CcSEcCtD
Dihydrocodeine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000251	0.00109	CcSEcCtD
Dihydrocodeine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000251	0.00109	CcSEcCtD
Dihydrocodeine—Headache—Prednisone—chronic obstructive pulmonary disease	0.00025	0.00108	CcSEcCtD
Dihydrocodeine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000249	0.0143	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000239	0.0137	CbGpPWpGaD
Dihydrocodeine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000237	0.00103	CcSEcCtD
Dihydrocodeine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00023	0.0132	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000211	0.0121	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000208	0.0119	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.0002	0.0114	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000198	0.0113	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000189	0.0108	CbGpPWpGaD
Dihydrocodeine—OPRM1—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.000189	0.0108	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—CD8A—chronic obstructive pulmonary disease	0.000188	0.0108	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000174	0.00994	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000167	0.00956	CbGpPWpGaD
Dihydrocodeine—OPRM1—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.00016	0.00912	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000157	0.00895	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000156	0.00889	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000152	0.00869	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00015	0.00858	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000148	0.00847	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000127	0.00725	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.00705	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.00703	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00011	0.00631	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000109	0.00623	CbGpPWpGaD
Dihydrocodeine—OPRM1—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000106	0.00606	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000102	0.00581	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—IL1B—chronic obstructive pulmonary disease	0.0001	0.00571	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	9.94e-05	0.00568	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	9.81e-05	0.00561	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	9.66e-05	0.00552	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	9.29e-05	0.00531	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.96e-05	0.00512	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.93e-05	0.00511	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	8.06e-05	0.00461	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	7.96e-05	0.00455	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	7.92e-05	0.00452	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.88e-05	0.0045	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.79e-05	0.00445	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	7.77e-05	0.00444	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	7.26e-05	0.00415	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.22e-05	0.00413	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.13e-05	0.00407	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	7.11e-05	0.00407	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	6.78e-05	0.00387	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.55e-05	0.00374	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.46e-05	0.00369	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	6.22e-05	0.00356	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	6.15e-05	0.00352	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	6.06e-05	0.00346	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.86e-05	0.00335	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—IL6—chronic obstructive pulmonary disease	5.85e-05	0.00335	CbGpPWpGaD
Dihydrocodeine—OPRM1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	5.73e-05	0.00328	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.46e-05	0.00312	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	5.46e-05	0.00312	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	5.42e-05	0.0031	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.39e-05	0.00308	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.15e-05	0.00294	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.09e-05	0.00291	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.02e-05	0.00287	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.96e-05	0.00283	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.95e-05	0.00283	CbGpPWpGaD
Dihydrocodeine—OPRM1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	4.84e-05	0.00276	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.8e-05	0.00274	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.76e-05	0.00272	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4.74e-05	0.00271	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.69e-05	0.00268	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.28e-05	0.00245	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.22e-05	0.00241	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.85e-05	0.0022	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.83e-05	0.00219	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.63e-05	0.00208	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.57e-05	0.00204	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.52e-05	0.00201	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.43e-05	0.00196	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.28e-05	0.00188	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.24e-05	0.00185	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.11e-05	0.00178	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.11e-05	0.00178	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.07e-05	0.00175	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.06e-05	0.00175	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.93e-05	0.00167	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.93e-05	0.00167	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.78e-05	0.00159	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.68e-05	0.00153	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.54e-05	0.00145	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.5e-05	0.00143	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.47e-05	0.00141	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.43e-05	0.00139	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.29e-05	0.00131	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.14e-05	0.00122	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.99e-05	0.00114	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.84e-05	0.00105	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.66e-05	0.000947	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.65e-05	0.000946	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.64e-05	0.000939	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.61e-05	0.000922	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.5e-05	0.000859	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.5e-05	0.000857	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.49e-05	0.000853	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.44e-05	0.000821	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.35e-05	0.00077	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.34e-05	0.000763	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.33e-05	0.000761	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.22e-05	0.000695	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.12e-05	0.00064	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.1e-05	0.000628	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.05e-05	0.000599	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1e-05	0.000572	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.34e-06	0.000534	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.21e-06	0.000526	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.88e-06	0.000507	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.81e-06	0.000504	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.71e-06	0.000498	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.58e-06	0.000491	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.44e-06	0.000482	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.14e-06	0.000465	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.03e-06	0.000459	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.95e-06	0.000454	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.32e-06	0.000418	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.21e-06	0.000412	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.62e-06	0.000378	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.49e-06	0.000371	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.11e-06	0.000349	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.02e-06	0.000344	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.61e-06	0.000321	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	5.53e-06	0.000316	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.45e-06	0.000311	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.32e-06	0.000304	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.29e-06	0.000302	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.99e-06	0.000285	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.62e-06	0.000207	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.46e-06	0.000198	CbGpPWpGaD
